BioNexus Gene Lab Corp (BGLC) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $6.34M | -22.9% |
| 2024 | $8.22M | -2.6% |
| 2023 | $8.44M | -12.7% |
| 2022 | $9.67M | -12.9% |
| 2021 | $11.10M | +14.7% |
| 2020 | $9.67M | +13507.7% |
| 2019 | $71.1K | +138.7% |
| 2018 | -$183.6K | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $6.34M | -22.9% |
| 2024 | $8.22M | -2.6% |
| 2023 | $8.44M | -12.7% |
| 2022 | $9.67M | -12.9% |
| 2021 | $11.10M | +14.7% |
| 2020 | $9.67M | +13507.7% |
| 2019 | $71.1K | +138.7% |
| 2018 | -$183.6K | — |